
Seed Oils: The Raging Health Debate you’ve Never Heard
Physionic
Jun 20, 2025
Episode description
*JOIN THE PHYSIONIC INSIDERS [PREMIUM CONTENT]*
Join the Physionic Insiders: https://bit.ly/PhysionicInsiders2
*HEALTH AUTONOMY [COURSE]*
Learn to Analyze & Apply Studies for Yourself: https://bit.ly/healthautonomy
*JOIN THE COMMUNITY*
Join my Community [It’s Free!]: https://bit.ly/PhysionicCommunity2
*EMAIL LIST*
1-2 Weekly Email of Value [It’s Free!]: http://bit.ly/2AXIzK6
*HIRE ME FOR CONSULTING:*
Consulting: https://bit.ly/3dmUl2H
Created with Biorender
0:00 - Introduction
1:40 - The Anti-Seed Oil Research
5:24 - The Debate Intensifies
8:59 - What does more recent Research say?
14:33 - Omega-6/Omega-3 Ratio
17:55 - Some Critical Information
23:15 - Main Points
References
[Study 467] Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr. 2010;104(11):1586-1600. doi:10.1017/S0007114510004010
Funding/Conflicts: Public Funding [NIAAA and NIH] / No direct Conflicts of Interest
[Study 468] Harris WS, Brouwer IA, Mozaffarian D. n-6 Fatty acids and risk for CHD: consider all the evidence. Br J Nutr. 2011;106(6):951-952. doi:10.1017/S000711451100105X.
Funding/Conflicts: No Funding / Potential direct Conflicts of Interest [Dr. William S. Harris has served as a speaker for GlaxoSmithKline and a consultant for several companies involved in omega-3 fatty acid research and products - truncated]
[Study 469] Ramsden CE, Hibbeln JR, Majchrzak-Hong SF, Davis JM. Don’t disregard the essential distinction between PUFA species. Br J Nutr. 2011;106(7):953-957. doi:10.1017/S0007114511001061
Funding/Conflicts: Public Funding [NIAAA and NIH] / No direct Conflicts of Interest
[Study 470] Hamley S. The effect of replacing saturated fat with mostly n–6 polyunsaturated fat on coronary heart disease: a meta-analysis of randomised controlled trials. Nutr J. 2017;16(1):30. doi:10.1186/s12937-017-0254-5
Funding/Conflicts: None
[Study 471] Hooper L, Martin N, Abdelhamid A, Davey Smith G. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2015;(6):CD011737. doi:10.1002/14651858.CD011737.pub2
Funding/Conflicts: Public Funding [NIH and CLAHRC] / No direct Conflicts of Interest
[Study 472] Wu JHY, Lemaitre RN, Imamura F, et al. Omega-6 fatty acid biomarkers and incident cardiovascular disease and death: an individual-level pooled analysis of 30 prospective cohort studies. Lancet Diabetes Endocrinol. 2014;2(10):856-865. doi:10.1016/S2213-8587(14)70126-2
Funding/Conflicts: Mixed Funding [Non-Profit: Bill & Melinda Gates Foundation; Public: NIH] / No direct Conflicts of Interest
[Study 473] Zhou H, Urpi-Sarda M, Tuladhar AM, et al. Plasma omega-6/omega-3 ratio and mortality: insights from 117,546 UK Biobank participants. eLife. 2022;11:e81751. doi:10.7554/eLife.81751
Funding/Conflicts: Public [National Natural Science Foundation of China] / No direct Conflicts of Interest
[Study 474] Yang WS, Chen YY, Chen PC, et al. Association between Plasma N-6 Polyunsaturated Fatty Acids Levels and the Risk of Cardiovascular Disease in a Community-based Cohort Study. Sci Rep. 2019;9:19298. doi:10.1038/s41598-019-55686-7
Funding/Conflicts: Internal Funding [Department of Internal Medicine at National Taiwan University Hospital] / No direct Conflicts of Interest
[Study 475] Woodhill JM, Palmer AJ, Leelarthaepin B, McGilchrist C, Blacket RB. Low fat, low cholesterol diet in secondary prevention of coronary heart disease. In: Kritchevsky D, ed. Drugs, Lipid Metabolism, and Atherosclerosis. New York, NY: Plenum Press; 1978:317-330.
Funding/Conflicts: Internal Funding [Department of Medicine, University of New South Wales, at Prince Henry Hospital, Little Bay, Australia] // No direct Conflicts of Interest
[Study 476] Ramsden CE, Zamora D, Leelarthaepin B, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013;346:e8707. doi:10.1136/bmj.e8707.
Funding/Conflicts: Public Funding [Intramural Research Program of the National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Aging (NIA)] / No direct Conflicts of Interest
[Study 477] Burr ML, Fehily AM, Rogers S, Welsby E, King S, Sandham S. Diet and reinfarction trial (DART): design, recruitment, and compliance. Eur Heart J. 1989;10(6):558-567.
Funding/Conflicts: Mixed Funding [Welsh Scheme for the Development of Health and Social Research, the Welsh Heart Foundation, and the Health Promotion Research Trust] // No direct Conflicts of Interest
Mindsip insights from this episode:
More from
Physionic

This New Protein Study just Changed how we Think about Protein!

The One Breakfast Food that Eliminates Fat, Protects the Liver, and Builds Muscle!

The Liver Effect of using Wegovy and Ozempic that Researchers Didn’t Expect

The Crunchy Add-On Linked to Less Visceral Fat and Preserving your Brain

It Crushes Visceral Fat, But the Scale Barely Moves!
You also might be interested in

I Drink Fat To Look Shredded (Lost 100lbs)

The Perfect Morning Routine for a Longer, Sharper Life | Dr. Mark Hyman

Gas, Bloating, Fatigue & Other Post-Meal Issues? Discover The NEW Autoimmune Protocol With Mickey Trescott

The Food Addiction Crisis: Why Millions Can’t Stop Eating Sugar | Jen Unwin

The Mental Health Crisis Starts in the Gut | Dr. William Li & Dr. Mark Hyman




